Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Recreational Physical Activity and Risk of Ovarian Cancer: a Meta-analysis

  • Zhou, Li-Min (Competitive Sports School Affiliated to Harbin Institute of Physical Education)
  • Published : 2014.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Our aim was to access the association between recreational physical activity (RPA) and risk of ovarian cancer (OC). The studies were retrieved from the PubMed and Embase databases up to February 20th, 2014. Risk ratios (OR) and 95% confidence intervals (CI) were used to estimate effect sizes. Random-effects or fixed-effects models were used to pool the data. The trim and fill method was applied for sensitivity analysis. Begg's rank correlation test and Egger's regression asymmetry test were employed to assess the publication bias. A total of 6 studies (435398 participants including 2983 OC patients) were included in this meta-analysis. The overall estimate indicated that there was weakly inverse association between RPA and OC risk (RR=0.90, 95%CI: 0.72-1.12, p=0.335). Meanwhile, for prospective cohort studies, a result consistent with the overall estimate was obtained (RR=1.12, 95% CI: 0.88-1.42, p=0.356). However, for case control studies, the pooled estimate of RR was 0.76 (95%CI: 0.64-0.90, p=0.002), indicating a clear significant association between RPA and OC risk. In addition, the sensitivity analysis indicated a significant link between RPA and risk of OC after removing Lahmann's study (RR=0.80, 95% CI: 0.68-0.93, p=0.004). No significant publication bias was found (Begg's test: p=1.00; Egger's test: p=0.817). In conclusion, our meta-analysis indicated a weakly inverse relationship between RPA and the occurrence of OC.

Keywords

References

  1. Ainsworth BE, Haskell WL, Whitt MC, et al (2000). Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc, 32, 498-504. https://doi.org/10.1097/00005768-200009001-00009
  2. Aktas G, Ogce F (2005). Dance as a therapy for cancer prevention. Asian Pac J Cancer Prev, 6, 408.
  3. Anderson JP, Ross JA , Folsom AR (2004). Anthropometric variables, physical activity, and incidence of ovarian cancer. Cancer, 100, 1515-21. https://doi.org/10.1002/cncr.20146
  4. Antoniou AC, Rookus M, Andrieu N, et al (2009). Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev, 18, 601-10. https://doi.org/10.1158/1055-9965.EPI-08-0546
  5. Begg CB , Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  6. Bertone ER, Newcomb PA, Willett WC, et al (2002). Recreational physical activity and ovarian cancer in a population-based case-control study. Int J Cancer, 99, 431-6. https://doi.org/10.1002/ijc.10365
  7. Bertone ER, Willett WC, Rosner BA, et al (2001). Prospective study of recreational physical activity and ovarian cancer. J Natl Cancer Inst, 93, 942-8. https://doi.org/10.1093/jnci/93.12.942
  8. Burger RA, Brady MF, Bookman MA, et al (2011). Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med, 365, 2473-83. https://doi.org/10.1056/NEJMoa1104390
  9. Campbell KL , McTiernan A (2007). Exercise and biomarkers for cancer prevention studies. J Nutr, 137, 161-9. https://doi.org/10.1093/jn/137.1.161S
  10. Cauley JA, Gutai JP, Kuller LH, et al (1989). The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol, 129, 1120-31. https://doi.org/10.1093/oxfordjournals.aje.a115234
  11. Cramer DW , Welch WR (1983). Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst, 71, 717-21.
  12. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
  13. Duval S, Tweedie R (2000). Trim and fill: a simple funnel-plot.based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56, 455-63. https://doi.org/10.1111/j.0006-341X.2000.00455.x
  14. Egger M, Smith GD, Schneider M , Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. Br Med J, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  15. Friedenreich CM (2001). Physical activity and cancer: lessons learned from nutritional epidemiology. Nutr Rev, 59, 349-57.
  16. Hannan LM, Leitzmann MF, Lacey JV, et al (2004). Physical activity and risk of ovarian cancer: a prospective cohort study in the United States. Cancer Epidemiol Biomarkers Prev, 13, 765-70.
  17. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. Br Med J, 327, 557. https://doi.org/10.1136/bmj.327.7414.557
  18. Kim JH, Jeong SJ, Kim B, et al (2012). Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells. J Pineal Res, 52, 244-52. https://doi.org/10.1111/j.1600-079X.2011.00935.x
  19. Kramer MM, Wells CL (1996). Does physical activity reduce risk of estrogen-dependent cancer in women? Med Sci Sports Exerc, 28, 322-34.
  20. Kruk J (2007). Physical activity in the prevention of the most frequent chronic diseases: an analysis of the recent evidence. Asian Pac J Cancer Prev, 8, 325.
  21. Kruk J, Aboul-Enein HY (2006). Physical activity in the prevention of cancer. Asian Pac J Cancer Prev, 7, 11.
  22. Lahmann PH, Friedenreich C, Schulz M, et al (2009). Physical activity and ovarian cancer risk: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev, 18, 351-4. https://doi.org/10.1158/1055-9965.EPI-08-0958
  23. Lee JE , Loh SY (2013). Physical activity and quality of life of cancer survivors: a lack of focus for lifestyle redesign. Asian Pac J Cancer Prev, 14, 2551-5. https://doi.org/10.7314/APJCP.2013.14.4.2551
  24. Lin J, Spidel JL, Maddage CJ, et al (2013). The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity. Cancer Biol Ther, 14, 1032-8. https://doi.org/10.4161/cbt.26106
  25. Munksgaard PS, Blaakaer J (2012). The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol, 124, 164-9. https://doi.org/10.1016/j.ygyno.2011.10.001
  26. Ness RB, Cottreau C (1999). Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst, 91, 1459-67. https://doi.org/10.1093/jnci/91.17.1459
  27. Pan SY, Johnson KC, Ugnat A-M, et al (2004). Association of obesity and cancer risk in Canada. Am J Epidemiol, 159, 259-68. https://doi.org/10.1093/aje/kwh041
  28. Pan SY, Ugnat AM , Mao Y (2005). Physical activity and the risk of ovarian cancer: a case-control study in Canada. Int J Cancer, 117, 300-7. https://doi.org/10.1002/ijc.21157
  29. Patel AV, Rodriguez C, Pavluck AL, et al (2006). Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women. Am J Epidemiol, 163, 709-16. https://doi.org/10.1093/aje/kwj098
  30. Riman T, Nilsson S, Persson IR (2004). Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand, 83, 783-95. https://doi.org/10.1080/j.0001-6349.2004.00550.x
  31. Risch HA (1998). Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst, 90, 1774-86. https://doi.org/10.1093/jnci/90.23.1774
  32. Rossing MA, Cushing-Haugen KL, Wicklund KG, et al (2010). Recreational physical activity and risk of epithelial ovarian cancer. Cancer Causes Control, 21, 485-91. https://doi.org/10.1007/s10552-009-9479-8
  33. Salehi F, Dunfield L, Phillips KP, et al (2008). Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev, 11, 301-21. https://doi.org/10.1080/10937400701876095
  34. Samuels Y, Waldman T (2011). Oncogenic mutations of PIK3CA in human cancers. Phosphoinositide 3-kinase in Health and Disease. Springer.
  35. Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011. CA Cancer J Clin, 61, 212-36. https://doi.org/10.3322/caac.20121
  36. Society AC (2005). Cancer facts & figures, Atlanta, GA: American Cancer Society.
  37. Tavani A, Gallus S, La Vecchia C, et al (2001). Physical activity and risk of ovarian cancer: an Italian case-control study. Int J Cancer, 91, 407-11. https://doi.org/10.1002/1097-0215(200002)9999:9999<::AID-IJC1065>3.3.CO;2-D
  38. Thune I (2000). Assessments of physical activity and cancer risk. Eur J Cancer Prev, 9, 387-93. https://doi.org/10.1097/00008469-200012000-00003
  39. Vainio H, Bianchini F (2002). Weight control and physical activity. IARC Handbooks of Cancer Prevention. IARC Press Lyon.
  40. Vaughan S, Coward JI, Bast RC, et al (2011). Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer, 11, 719-25. https://doi.org/10.1038/nrc3144
  41. Wang B1, Liu SZ, Zheng RS, et al (2014). Time trends of ovarian cancer incidence in China. Asian Pac J Cancer Prev, 15, 191-3. https://doi.org/10.7314/APJCP.2014.15.1.191
  42. Wells G, Shea B, O'connell D, et al (2011). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. URL: http://www. ohri. ca/programs/clinical_epidemiology/oxford. asp
  43. Westerlind KC (2003). Physical activity and cancer prevention-mechanisms. Med Sci Sports Exerc, 35, 1834-40. https://doi.org/10.1249/01.MSS.0000093619.37805.B7
  44. Wu SPL, Cao HX, Liu YT, et al (2009). Body size, physical activity and risk of breast cancer.a case control study in Jangsu Province of China. Asian Pac J Cancer Prev, 10, 877-81.
  45. Zhang M, Lee AH, Binns CW (2003). Physical activity and epithelial ovarian cancer risk: a case-control study in China. Int J Cancer, 105, 838-43. https://doi.org/10.1002/ijc.11165
  46. Zhao SH, Wang Y, Wen L, et al (2013). Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer. J Transl Med, 11, 92. https://doi.org/10.1186/1479-5876-11-92

Cited by

  1. Myeloid Differentiation Factor 88 Promotes Cisplatin Chemoresistance in Ovarian Cancer vol.71, pp.2, 2015, https://doi.org/10.1007/s12013-014-0294-9
  2. Physical activity, sitting time, and the risk of ovarian cancer: A brief research report employing a meta-analysis of existing pp.1096-4665, 2018, https://doi.org/10.1080/07399332.2018.1505892
  3. Association between dietary fiber intake and risk of ovarian cancer: a meta-analysis of observational studies vol.46, pp.10, 2018, https://doi.org/10.1177/0300060518792801